Inflammatory Bowel Disease

The Melbourne Gastrointestinal Investigation Unit provide a number of treatment and therapy options for Inflammatory Bowel Disease (IBD).

These options include:

  • treatment by injection with the immunomodulator, Methotrexate.
  • treatment with the biologics: Humira [Adalimumab], Remicade [Infliximab] & Entyvio [Vedolizumab].

As part of your treatment, we:

  • organise baseline tests.
  • advise regarding pre-treatment vaccination.
  • educate you in the use of the drug and any potential side effects.
  • our nursing staff will teach you to self-administer the injections & safe disposal of the sharps.
  • Provide regular treatment by injection or provide infusions with biologics drugs when needed.
  • Provide infusions with biologics drugs when needed.
  • Some tests, including faecal calprotectin and infliximab levels, are tested directly in our lab.

Research drug trials

A/Prof Henry Debinski participates in a number of research drug trials involving new therapies for both Crohn’s disease and ulcerative colitis that are supervised by MGIU.